Trial NCT02945813

View at ClinicalTrials.gov 
Org. Study IDs: SAKK 08/15 - PROMET
Secondary IDs: 2016-003599-39

Last trial update was posted on 2022-04-14

MeSH Interventions

Metformin

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Prostate Cancer

Stopping Reasons

Trial was prematurely closed for accrual by the SAKK Board and the follow-up period shortened to one year after last RT fraction of the last patient

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID